NEW YORK, May 3 (GenomeWeb News) - Cellectricon and AstraZeneca will "study the possibility" of developing a new cell-based microfluidic screening platform, Cellectricon said today.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Germany's Project DEAL has come to an agreement with the publisher Wiley over journal access and open-access publishing, ScienceInsider reports.
Researchers uncover additional loci associated with lifespan, which the Telegraph says could be folded into a genetic test.
A Canadian panel recommends public coverage of the gene therapy Kymriah if its cost comes down, the Globe and Mail reports.
In Nucleic Acids Research this week: new accurate quantification by sequencing approach, CNV breakpoints in Plasmodium falciparum, and more.